Abstract
Mutations in Leucine-rich repeat kinase 2 (LRRK2) are associated with Parkinson's disease (PD) and, as such, LRRK2 is considered a promising therapeut......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
